Connect with:
Tuesday / April 16. 2024

logo
mobile-logo
HomePosts Tagged "Bee Vectoring Technologies International Inc."
Agrotech, Company News, North America, R&D

Year 2 trial data established that adding CR-7 over base seed treatment results in soybean plants producing higher yields as measured over 16 replicated plots across four locations.

Bee Vectoring Technologies International Inc. is pleased to announce positive second year trial results demonstrating the efficacy of BVT’s proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) as a seed treatment on soybeans.

Compared to the first-year trials, the second year included measuring CR-7’s effect on soybean yields. Year 2 trial data established that adding CR-7 over base seed treatment results in soybean plants producing higher yields as measured over 16 replicated plots across four locations when compared to the biological standard, and that CR-7 was equivalent to the chemical standard in terms of effectiveness. Other measures on plant health, vigor and plant biomass showed the same positive outcomes as in the first year, indicating the scalability of BVT’s proprietary CR-7 in the soybean seed treatment market.

“Wherever CR-7 was applied, the results outperformed the base seed treatment 81 per cent of the time. We observed, on average, a three-bushel yield per acre increase with CR-7 added, which is about 4 per cent higher than the base seed treatment. Although that may not sound dramatic, that is a meaningful improvement for a treatment that was applied at the very early stages of the planting season. Most seed treatments are designed to protect the seed from pests, but to see a positive increase in the yield at the end of the season is impressive,” said Dr Mason Newark, Field Technical Manager at BVT.

Year 1 and 2 trials were conducted in partnership with well-established soybean researchers in Iowa, Illinois, and Wisconsin, with a fourth location in Nebraska added in 2022 and resulted in consistently positive results year over year across all the states that have had trials so far. The 2022 trials continued assessing the efficacy of CR-7 added over base seed treatment on plant biomass and vigor, and demonstrated its effectiveness as a treatment against disease and soybean crop yields.

“Our corporate market strategy is to initially focus on soybeans as it’s a major row crop where major multinationals are heavily invested in,” said Ashish Malik, CEO of BVT. There are 320 million acres grown globally, with 86 million acres in the US, 98 million in Brazil and 40 million in Argentina. (1) 80 per cent of American soybeans receive seed treatment before planting, and approximately 50 per cent undergo a biological inoculant treatment.

The seed treatment market is specialized, with different and distinct channels in the major growing regions. A deep understanding of the genetics of seed varieties, and access to the distinct channels, including relationships with seed companies, are important to successfully penetrate the market. BVT intends to partner with seed treatment companies who have the expertise and channel access to accelerate our reach into this soybean acreage. BVT believes future licensing agreements hold potential for significant annual royalties from this application.

Year 2 trial data established that adding

Agrotech, Company News, North America, Organic

CEA involves growing crops indoors in a highly conditioned environment as the most common forms are greenhouse and vertical farming

Bee Vectoring Technologies International Inc. has announced its first sales commitment in the growing Controlled Environment Agriculture (“CEA”) market. This key customer is a leading industry innovator in vertical farming with multiple US locations and will be conducting a paid pilot of the BVT system as a crop productivity tool.

CEA involves growing crops indoors in a highly conditioned environment as the most common forms are greenhouse and vertical farming. Entering this sector is a significant growth opportunity for BVT given the global CEA market was valued at over US$74 billion in 2021 and is estimated to reach US$125 billion by 2027.

“CEA is the future of agriculture, in particular for fresh produce,” said Ian Collinson, Sales Manager at BVT. “Growing crops vertically means we can grow more efficiently with greater yield and can be closer to urban centers where the bulk of fresh produce is consumed. It also means growers are no longer dependent on weather conditions, and therefore can operate 365 days a year with far less risk from external factors than traditional farming.”

This innovative agriculture method has several planet-friendly benefits. Farming vertically means 4-6 acres’ worth of crops can be grown in a single indoor acre. The ability to grow food closer to major population centres limits the carbon footprint that results from transportation across great distances. Plus, this process uses 70-90% less water than conventional outdoor methods, and requires significantly fewer pesticides, fertilizers and far less heavy machinery.

“BVT is committed to helping farmers of all circumstances,” said Collinson. “We are pleased and excited to enter the growing CEA market. BVT’s natural precision agriculture system, which is OMRI-listed for organic use, can help indoor growers’ productivity by helping them produce better quality fruits and vegetables – and provide consumers with premium products.”

CEA involves growing crops indoors in a

Agrotech, Company News, R&D

Brazil represents a great opportunity for BVT to further market a foliar and soil-applied version of CR-7

Canada based Bee Vectoring Technologies International Inc. has announced that the Company has been granted a patent for BVT’s Clonostachys rosea CR-7 microbial strain (CR-7) in Brazil for use as a biological control agent in agriculture.

The Brazil patent grant (Patent Number BR112016005139-4) recognizes the unique properties of BVT’s proven CR-7 strain. It covers the use of CR-7 in any application method, in any formulation (solid or liquid), for yield improvement, and for disease control.

Brazil represents a significant market opportunity for BVT across specialty and row crops. It has a vast diversity of fruit and vegetable crops and is also the largest soybean producer in the world, with an estimated 140 million tonnes grown annually on about 100 million acres. It is also the world’s largest soybean exporter, with annual exports estimated at 90 million tonnes.

“We are making significant advancements in soybean seed treatment in the United States, and extending the work into Brazil is the next logical step in scaling our business,” said Ashish Malik, CEO of BVT. “Brazil also represents a great opportunity for BVT to further market a foliar and soil-applied version of CR-7, and we are continuing to evaluate the opportunities for the bee vectoring process despite a more limited commercial pollination services industry compared to the United States.”

Malik also added that BVT’s inroads into Brazil are ground breaking. It’s rare for their authorities to allow a company to patent naturally-occurring microbial strains. The fact that we have been granted a patent for CR-7 speaks to how compelling and proprietary our technology really is. Having a patent-protected product paves the way for significant market entry opportunities with business partners in Brazil. It’s a key part of our strategy to strongly position BVT to capture global market share.”

BVT has had over 65 patents granted and currently has more than 35 pending in all major agricultural regions worldwide, including North America, South America, Europe, Asia and Australia.

Brazil represents a great opportunity for BVT